Document:

Exhibit 10.6

Exhibit 10.6

EXECUTION VERSION

AMENDED AND RESTATED SECURITY AGREEMENT

AMENDED AND RESTATED SECURITY AGREEMENT, is entered into as of September 23, 2010 with an
effective date of August 30, 2010 as amended or otherwise modified from time to time, this
“Agreement”), among Biolase Technology, Inc., a Delaware corporation (“Biolase”),
BL Acquisition Corp., a Delaware corporation (“BL Acquisition”) and BL Acquisition II Inc.,
a Delaware corporation (“BL Acquisition II”, together with Biolase and BL Acquisition,
“Grantors” and each a “Grantor”), and Henry Schein, Inc., a Delaware corporation
(“HSI”).

Reference is made to each of (x) the security agreement, dated February 16, 2010 (as amended
or otherwise modified prior to the date hereof, the “Prior Security Agreement”), between
HSI and Biolase and (y) the Distribution and Supply Agreement, dated the date hereof (as amended or
otherwise modified from time to time, the “Distribution Agreement”), between HSI and
Biolase.

The Prior Security Agreement creates a security interest in all of Biolase’s inventory (and
products and proceeds thereof) to secure obligations of Biolase to HSI under the letter agreement,
dated February 16, 2010 (as amended or otherwise modified prior to the date hereof, the
“February Letter”), between HSI and Biolase.

The Distribution Agreement, among other things, (x) continues the obligations owed by Biolase
under the February Letter (such obligations, as continued under the Distribution Agreement, are
herein referred to as the “February Obligations”), (y) continues the obligations of Biolase
to HSI under the letter agreement, dated March 9, 2010 (as amended or otherwise modified prior to
the date hereof, the “March Letter”), between HSI and Biolase (such obligations, as
continued under the Distribution Agreement, are herein referred to as the “March
Obligations”) and (z) creates obligations from Biolase owing to HSI in addition to the February
Obligations and March Obligations, in each case as more fully described therein.

This Agreement (i) amends and restates in its entirety the Prior Security Agreement, (ii)
continues the security interests granted by Biolase under the Prior Security Agreement securing
obligations of Biolase under the February Letter and (iii) otherwise secures all obligations of
Biolase under the Distribution Agreement. The Prior Security Agreement has been superseded in its
entirety by this Agreement, and shall no longer be in effect except as modified herein. This
Agreement does not constitute a novation.

As a condition to entering into the Distribution Agreement, HSI shall have received (i)
evidence satisfactory to HSI that the requisite lenders under the Loan and Security Agreement,
dated as of May 27, 2010 (as amended and otherwise modified prior to the date hereof, the
“MidCap Loan Agreement”), among Biolase, MidCap Funding III, LLC, Silicon Valley Bank and
the other lenders party thereto have entered into an agreement with Biolase, the terms of which
shall be reasonably satisfactory to HSI and (ii) take all action necessary to perfect the security
interests granted (and continued) under Section 2 (other than actions to be taken post closing in
accordance with the last sentence of Section 4).

 

 

 

NOW, THEREFORE, in consideration of the promises contained herein and for other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties
hereto agree as follows:

1. Definitions.

All capitalized terms used herein shall have the meanings provided herein (including, without
limitation, the meanings provided in Schedule I). Capitalized terms used herein without
meanings provided herein shall have the respective meanings provided therefor in the Distribution
Agreement.

2. Grant of Security Interest. Each Grantor hereby grants to HSI, to secure the
payment and performance in full of all of the Obligations, a continuing security interest in, and
pledges to HSI, the Collateral, wherever located, whether now owned or hereafter acquired or
arising, and all proceeds and products thereof.

Each Grantor represents, warrants, covenants and confirms that (i) Biolase granted a security
interest under the Prior Security Agreement in all of Biolase’s right, title and interest in its
inventory (and products and proceeds thereof) to secure the obligations of Biolase under the
February Letter and (ii) such obligations are continued under the Distribution Agreement and such
security interest is continued hereunder. Each Grantor further represents, warrants and covenants
that the security interest granted herein (and continued herein) is and shall at all times
continue to be a Senior Priority perfected security interest. “Senior Priority” means (a)
with respect to the perfected security interest in the inventory (and products and proceeds
thereof) of Biolase to secure the February Obligations, a first priority perfected security
interest, subject in priority only to Permitted Liens that may have priority by operation of
applicable Law and (b) with respect to the perfected security interest in the Collateral to secure
all Obligations, a first priority perfected security interest subject in priority only to
Permitted Liens that may have priority by operation of applicable Law and Liens securing the
obligations (but only up to an aggregate principal amount of $3,000,000) of Biolase under the
MidCap Loan Agreement.

3. Authorization to File Financing Statements. Each Grantor hereby authorizes HSI to
file financing statements, without notice to it, in all appropriate jurisdictions to perfect or
protect HSI’s interest or rights hereunder, including, without limitation, a notice that any
disposition of the Collateral, by either any Grantor or any other Person, shall be deemed to
violate the rights of HSI under the UCC. Such financing statements may indicate the Collateral as
“all assets of Debtor” or words of similar effect, or as being of an equal or lesser scope, or
with greater detail, all in HSI’s discretion.

 

2

 

4. Other Actions as to Any and All Collateral. Each Grantor agrees, at the request
and option of HSI, to take any and all other actions HSI may determine to be necessary or useful
for the attachment, perfection and Senior Priority of, and the ability of HSI to enforce, HSI’s
security interest in any and all of the Collateral, including, without limitation, (a) executing
any further instruments (including, without limitation, intellectual property security agreements
and control agreements) and taking further action (including, without limitation, delivery of
Collateral that can only be perfected by possession) as HSI reasonably requests to
perfect or continue HSI’s security interest in the Collateral or to effect the purposes of
this Agreement, (b) delivering and, where appropriate, filing financing statements and amendments
relating thereto under the UCC, (c) causing HSI’s name to be noted as secured party on any
certificate of title for a titled good if such notation is a condition to attachment, perfection
or priority of, or ability of HSI to enforce, HSI’s security interest in such Collateral, (d)
complying with any provision of any statute, regulation or treaty of the United States as to any
Collateral if compliance with such provision is a condition to attachment, perfection or priority
of, or ability of HSI to enforce, HSI’s security interest in such Collateral, (e) obtaining
governmental and other third party waivers, consents and approvals in form and substance
satisfactory to HSI, including, without limitation, any consent of any licensor, lessor or other
person obligated on Collateral and (f) taking all actions under any earlier versions of the UCC or
under any other law, as reasonably determined by HSI to be applicable in any relevant UCC or other
jurisdiction, including, without limitation, any foreign jurisdiction. If a Grantor shall acquire
a commercial tort claim (as defined in the UCC), it shall promptly notify HSI in a writing signed
by it of the general details thereof (and further details as may be required by HSI) and grant to
HSI, in such writing a security interest therein and in the proceeds thereof, all upon the terms
of this Agreement, with such writing to be in form and substance reasonably satisfactory to HSI.
Without limiting the generality of the foregoing, each Grantor will execute and deliver deposit
account control agreements for any deposit accounts constituting Collateral no later than [fifteen
(15)] days after the date hereof.

5. Representations and Warranties. Each Grantor makes the representations and
warranties set forth on Schedule II hereto.

6. Covenants. Each Grantor agrees with HSI to comply with each of the covenants set
forth on Schedule III hereto.

7. Events of Default. Any one or more of the events, actions or omissions set forth
on Schedule IV shall constitute an event of default (an “Event of Default”).

8. Rights and Remedies.

	 	(a)	 	Upon the occurrence and during the continuance of an Event of
Default, HSI shall have the right to do any or all of the following: (i)
deliver notice of the Event of Default to the Grantors, (ii) by notice to the
Grantors declare all Obligations immediately due and payable (but if an Event
of Default described in clause (c) of Schedule IV occurs all
Obligations shall be immediately due and payable without any action by HSI) or
(iii) by notice to the Grantors suspend or terminate the obligations, if any,
of HSI to advance money or extend credit for Biolase’s benefit under the
Distribution Agreement (but if an Event of Default described in clause (c) of
Schedule IV occurs all obligations, if any, of HSI to advance money or
extend credit for Biolase’s benefit under the Distribution Agreement).

 

3

 

	 	(b)	 	Without limiting the rights of HSI set forth in the paragraph
above, upon the occurrence and during the continuance of an Event of Default
HSI shall have the right, without notice or demand, to do any or all of the
following:

(i) foreclose upon and/or sell or otherwise liquidate the Collateral,
but use commercially reasonable efforts to first foreclose upon and/or sell
or otherwise liquidate, the Collateral consisting of assets other than
Intellectual Property; provided that (A) in instances in which any
other Person has initiated foreclosure on Intellectual Property, HSI shall
be entitled to join such action subject to any restrictions in an agreement
between HSI and such Person; (B) in any foreclosure on Intellectual Property
or in any sale of Intellectual Property in any Insolvency Proceeding, HSI
shall not bid to obtain title to Intellectual Property if the Obligations
owing to HSI have been indefeasibly paid in full;  and  (C) except as
expressly provided, this clause (i) shall not be in any manner restrict or
limit HSI’s rights and remedies with respect to (x) any foreclosure
instituted or continued by HSI or any other Person, or (y) any Insolvency
Proceeding;

(ii) apply to the Obligations any (a) balances and deposits of any
Grantor that HSI holds or controls, or (b) any amount held or controlled by
HSI owing to or for the credit or the account of any Grantor; and/or

(iii) commence, join in and prosecute an Insolvency Proceeding or
consent to any Grantor commencing any Insolvency Proceeding.

9. Standards for Exercising Rights and Remedies. To the extent that applicable law
imposes duties on HSI to exercise remedies in a commercially reasonable manner, each Grantor
acknowledges and agrees that it is not commercially unreasonable for HSI, subject in all cases to
its agreement with regard to Collateral consisting of Intellectual Property set forth in Section
8(b)(i) above, (a) to fail to incur expenses reasonably deemed significant by HSI to prepare
Collateral for disposition or otherwise to fail to complete raw material or work in process into
finished goods or other finished products for disposition, (b) to fail to obtain third party
consents for access to Collateral to be disposed of, or to obtain or, if not required by other
law, to fail to obtain governmental or third party consents for the collection or disposition of
Collateral to be collected or disposed of, (c) to fail to remove liens or encumbrances on or any
adverse claims against Collateral, (d) to exercise collection remedies against persons obligated
on Collateral directly or through the use of collection agencies and other collection specialists,
(e) to advertise dispositions of Collateral through publications or media of general circulation,
whether or not the Collateral is of a specialized nature, (f) to contact other persons, whether or
not in the same business as any Grantor, for expressions of interest in acquiring all or any
portion of the Collateral, (g) to hire one or more professional auctioneers to assist in the
disposition of Collateral, whether or not the collateral is of a specialized nature, (h) to
dispose of Collateral by utilizing Internet sites that provide for the auction of assets of the
types included in the Collateral or that have the reasonable capability of doing so, or that match
buyers and sellers of assets, (i) to dispose of assets in wholesale rather than retail markets, or
(j) to disclaim disposition warranties. Each Grantor acknowledges that the purpose of this
Section 9 is to provide non-exhaustive indications of what actions or omissions by HSI would
fulfill HSI’s duties under the UCC or other law of the State or any other relevant jurisdiction in
HSI’s exercise of remedies against the Collateral and that other actions or omissions by HSI
shall not be deemed to fail to fulfill such duties solely on account of not being indicated
in this Section 9. Without limitation upon the foregoing, nothing contained in this Section 9
shall be construed to grant any rights to any Grantor or to impose any duties on HSI that would
not have been granted or imposed by this Agreement or by applicable law in the absence of this
Section 9.

 

4

 

10. Collateral Protection Expenses; Preservation of Collateral.

	 	(a)	 	Expenses Incurred by HSI. In HSI’s discretion, if a
Grantor fails to do so, HSI may discharge taxes and other encumbrances at any
time levied or placed on any of the Collateral, maintain any of the Collateral,
make repairs thereto and pay any necessary insurance premiums. Each Grantor
agrees to reimburse HSI on demand for all expenditures so made. HSI shall have
no obligation to any Grantor to make any such expenditures.

	 	(b)	 	HSI’s Obligations and Duties. HSI’s sole duty with
respect to the custody, safe keeping and physical preservation of the
Collateral in its possession, if any, under Section 9-207 of the UCC of the
State or otherwise, shall be to deal with such Collateral in the same manner as
HSI deals with similar property for its own account.

11. Set-off. Regardless of the adequacy of Collateral or any other security for the
Obligations, any deposits or other sums at any time credited by or due from HSI to any Grantor may
at any time be applied to or set off against any of the Obligations.

12. Appointment and Powers of HSI.

	 	(a)	 	Each Grantor hereby irrevocably constitutes and appoints HSI
and any officer or agent thereof, with full power of substitution, as its true
and lawful attorneys-in-fact with full irrevocable power and authority in the
place and stead of any Grantor, as applicable, or in HSI’s own name, for the
purpose of carrying out the terms of this Agreement, to take any and all
appropriate action and to execute any and all documents and instruments that
may be necessary or useful to accomplish the purposes of this Agreement and,
without limiting the generality of the foregoing, hereby gives said attorneys
the power and right, on behalf of it, without notice to or assent by it, to do
the following:

(i) subject to the proviso set forth in Section 9(b), upon the
occurrence and during the continuance of an Event of Default, generally to
sell, transfer, pledge, make any agreement with respect to or otherwise
dispose of or deal with any of the Collateral in such manner as is
consistent with the UCC of the State and as fully and completely as though
HSI were the absolute owner thereof for all purposes, and to do, at a
Grantor’s expense, at any time, or from time to time, all acts and things
which HSI deems necessary or useful to protect, preserve or realize upon the
Collateral and HSI’s security interest therein, in order to effect the
intent of this Agreement, all at least as fully and effectively as a
Grantor might do; and

 

5

 

(ii) to the extent that a Grantor’s authorization given in Section 3 is
not sufficient, to file such financing statements with respect hereto, with
or without its’ signature, or a photocopy of this Agreement in substitution
for a financing statement, as HSI may deem appropriate and to execute in
such Grantor’s name such financing statements and amendments thereto and
continuation statements which may require its’ signature.

	 	(b)	 	Ratification by the Grantors. To the extent permitted
by law, each Grantor hereby ratifies all that said attorneys shall lawfully do
or cause to be done by virtue hereof. This power of attorney is a power
coupled with an interest and is irrevocable.

	 	(c)	 	No Duty on HSI. The powers conferred on HSI hereunder
are solely to protect its interests in the Collateral and shall not impose any
duty upon it to exercise any such powers. HSI shall be accountable only for
the amounts that it actually receives as a result of the exercise of such
powers, and neither it nor any of its officers, directors, employees or agents
shall be responsible to any Grantor for any act or failure to act, except for
HSI’s own gross negligence or willful misconduct.

 

6

 

13. No Waiver by HSI, etc. HSI shall not be deemed to have waived any of its rights
or remedies in respect of the Obligations or the Collateral unless such waiver shall be in writing
and signed by HSI. No delay or omission on the part of HSI in exercising any right or remedy
shall operate as a waiver of such right or remedy or any other right or remedy. A waiver on any
one occasion shall not be construed as a bar to or waiver of any right or remedy on any future
occasion. All rights and remedies of HSI with respect to the Obligations or the Collateral,
whether evidenced hereby or by any other instrument or papers, shall be cumulative and may be
exercised singularly, alternatively, successively or concurrently at such time or at such times as
HSI deems expedient.

14. Suretyship Waivers by Grantor. Each Grantor waives demand, notice, protest,
notice of acceptance of this Agreement, credit extended, Collateral received or delivered or other
action taken in reliance hereon and all other demands and notices of any description. With
respect to both the Obligations and the Collateral, each Grantor assents to any extension or
postponement of the time of payment or any other indulgence, to any substitution, exchange or
release of or failure to perfect any security interest in any Collateral, to the addition or
release of any party or person primarily or secondarily liable, to the acceptance of partial
payment thereon and the settlement, compromising or adjusting of any thereof, all in such manner
and at such time or times as HSI may deem advisable. HSI shall have no duty as to the collection
or protection of the Collateral or any income therefrom, the preservation of rights against prior
parties, or the preservation of any rights pertaining thereto beyond the safe custody thereof as
set forth in Section 10(b). Each Grantor further waives any and all other suretyship defenses.

15. Marshalling. HSI shall not be required to marshal any present or future
collateral security (including, without limitation, the Collateral) for, or other assurances of
payment of, the Obligations or any of them or to resort to such collateral security or other
assurances of payment in any particular order, and all of its rights and remedies hereunder and in
respect of such collateral security and other assurances of payment shall be cumulative and in
addition to all other rights and remedies, however existing or arising. To the extent that it
lawfully may, each Grantor hereby agrees that it will not invoke any law relating to the
marshalling of collateral which might cause delay in or impede the enforcement of HSI’s rights and
remedies under this Agreement or under any other instrument creating or evidencing any of the
Obligations or under which any of the Obligations is outstanding or by which any of the
Obligations is secured or payment thereof is otherwise assured, and, to the extent that it
lawfully may, each Grantor hereby irrevocably waives the benefits of all such laws.

16. Insurance Proceeds; Proceeds of Dispositions; Expenses. The proceeds of any
casualty insurance in respect of any casualty loss of any of the Collateral shall, subject to the
rights, if any, of other parties with an interest having priority in the property covered thereby,
(i) to the extent that the amount of such proceeds is less than $50,000, be disbursed to a
Grantor, as applicable, for direct application by it solely to the repair or replacement of its’
property so damaged or destroyed, and (ii) in all other circumstances, be held by HSI as cash
collateral for the Obligations. HSI may, at its sole option, disburse from time to time all or
any part of such proceeds so held as cash collateral, upon such terms and conditions as HSI may
reasonably prescribe, for direct application by a Grantor solely to the repair or replacement of
its’ property so damaged or destroyed, or HSI may apply all or any part of such proceeds to
the Obligations.

 

7

 

Each Grantor shall pay to HSI on demand any and all expenses, including, without limitation,
reasonable attorneys’ fees and disbursements, incurred or paid by HSI in protecting, preserving or
enforcing HSI’s rights and remedies under or in respect of any of the Obligations or any of the
Collateral. After deducting all of said expenses, the residue of any proceeds of collection or
sale or other disposition of the Collateral shall, to the extent actually received in cash, be
applied to the payment of the Obligations in such order or preference as HSI may determine proper
allowance and provision being made for any Obligations not then due. Upon the final payment and
satisfaction in full of all of the Obligations and after making any payments required by Sections
9-608(a)(1)(C) or 9-615(a)(3) of the UCC of the State, any excess shall be returned to the
Grantors. In the absence of final payment and satisfaction in full of all of the Obligations,
each Grantor shall remain liable for any deficiency.

17. Termination Statements. Immediately upon satisfaction of the Obligations, HSI
shall authorize each Grantor, on behalf of such Grantor and at such Grantor’s expense, to execute
and file termination statements in all jurisdictions in which financing statements were filed in
respect of this Agreement, and shall take such other action or refrain from taking any other
action as such Grantor may reasonably request, and at such Grantor’s sole expense, to effectuate
the termination of this Agreement and the termination of perfection of any security interest
granted in and to the Collateral.

18. Governing Law; Consent to Jurisdiction. THIS AGREEMENT IS INTENDED TO TAKE
EFFECT AS A SEALED INSTRUMENT AND SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS
OF THE STATE OF NEW YORK. Each Grantor agrees that any action or claim arising out of, or any
dispute in connection with, this Agreement, any rights, remedies, obligations, or duties
hereunder, or the performance or enforcement hereof or thereof, may be brought in the courts of
the State or any federal court sitting therein and consents to the non-exclusive jurisdiction of
such court and to service of process in any such suit being made upon a Grantor by mail at the
address set forth on the signature page hereto. Each Grantor hereby waives any objection that it
may now or hereafter have to the venue of any such suit or any such court or that such suit is
brought in an inconvenient court.

19. Waiver of Jury Trial. THE DEBTOR WAIVES ITS RIGHT TO A JURY TRIAL WITH RESPECT
TO ANY ACTION OR CLAIM ARISING OUT OF ANY DISPUTE IN CONNECTION WITH THSI AGREEMENT, ANY RIGHTS,
REMEDIES, OBLIGATIONS, OR DUTIES HEREUNDER, OR THE PERFORMANCE OR ENFORCEMENT HEREOF OR THEREOF.
Except as prohibited by law, each Grantor waives any right which it may have to claim or recover
in any litigation referred to in the preceding sentence any special, exemplary, punitive or
consequential damages or any damages other than, or in addition to, actual damages. Each Grantor
(i) certifies that neither HSI nor any representative, agent or attorney of HSI has represented,
expressly or otherwise, that HSI would not, in the event of litigation, seek to enforce the
foregoing waivers or other waivers contained in this Agreement, and (ii) acknowledges that, in
entering into the Distribution Agreement, HSI is relying upon, among other things, the waivers and
certifications contained in this Section 19.

 

8

 

20. Indemnification.

	 	(a)	 	Each Grantor agrees to indemnify, defend and hold HSI and its
respective directors, officers, employees, agents, attorneys, or any other
Person affiliated with or representing HSI (each, an “Indemnified
Person”) harmless against: (a) all obligations, demands, claims, and
liabilities (collectively, “Claims”) asserted by any other party in
connection with the transactions contemplated by this Agreement or the
Distribution Agreement; and (b) all losses or HSI’s expenses incurred, or paid
by Indemnified Person from, following, or arising from transactions between HSI
and any Grantor (including, without limitation, reasonable attorneys’ fees and
expenses), except for Claims and/or losses directly caused by such Indemnified
Person’s gross negligence, willful misconduct or fraud (collectively, the
“Indemnified Liabilities”).

	 	(b)	 	Each Grantor hereby further indemnifies, defends and holds each
Indemnified Person harmless from and against any and all liabilities,
obligations, losses, damages, penalties, actions, judgments, suits, claims,
costs, expenses and disbursements of any kind or nature whatsoever (including,
without limitation, the fees and disbursements of counsel for such Indemnitee),
except to the extent directly caused by such Indemnified Person’s gross
negligence, willful misconduct or fraud, in connection with any investigative,
response, remedial, administrative or judicial matter or proceeding, whether or
not such Indemnified Person shall be designated a party thereto and including
any such proceeding initiated by or on behalf of any Grantor, and the
reasonable expenses of investigation by engineers, environmental consultants
and similar technical personnel and any commission, fee or compensation claimed
by any broker (other than any broker retained by HSI) asserting any right to
payment for the transactions contemplated hereby which may be imposed on,
incurred by or asserted against such Indemnified Person as a result of or in
connection with the transactions contemplated hereby and the use or intended
use of the proceeds of the loan proceeds.

	 	(c)	 	To the extent that the undertaking set forth in this Section 20
may be unenforceable, each Grantor shall contribute the maximum portion which
it is permitted to pay and satisfy under applicable law to the payment and
satisfaction of all such indemnified liabilities incurred by the Indemnitees or
any of them.

21. Miscellaneous. The headings of each section of this Agreement are for
convenience only and shall not define or limit the provisions thereof. This Agreement and all
rights and obligations hereunder shall be binding upon each Grantor and its respective successors
and assigns, and shall inure to the benefit of HSI and its successors and assigns. If any term of
this Agreement shall be held to be invalid, illegal or unenforceable, the validity of all other
terms hereof shall in no way be affected thereby, and this Agreement shall be construed and be
enforceable as if such invalid, illegal or unenforceable term had not been included herein. Each
Grantor acknowledges receipt of a copy of this Agreement.

 

9

 

IN WITNESS WHEREOF, intending to be legally bound, Grantor has caused this Agreement to be
duly executed as of the date first above written.

	 	 	 	 	 
	 	BIOLASE TECHNOLOGY, INC.

 	 
	 	By:  	/s/ Federico Pignatelli
 	 
	 	 	Name:  	Federico Pignatelli 	 
	 	 	Title:  	Chairman and interim Chief Executive Officer 	 

	 	 	 	 	 
	 	Organizational ID: Delaware No. 2117279

Address: 4 Cromwell, Irvine, California 92618

BL ACQUISITION CORP.

 	 
	 	By:  	/s/ Federico Pignatelli
 	 
	 	 	Name:  	Federico Pignatelli 	 
	 	 	Title:  	Chairman and interim Chief Executive Officer 	 

	 	 	 	 	 
	 	Organizational ID: Delaware No.

Address:

BL ACQUISITION II INC.

 	 
	 	By:  	/s/ Federico Pignatelli
 	 
	 	 	Name:  	Federico Pignatelli 	 
	 	 	Title:  	Chairman and interim Chief Executive Officer 	 

	 	 	 	 	 
	 	Organizational ID: Delaware No.

Address:

HENRY SCHEIN, INC.

 	 
	 	By:  	/s/ Mark E. Mlotek
 	 
	 	 	Name:  	Mark E. Mlotek 	 
	 	 	Title:  	Executive Vice President 	 
	 

 

10

 

Schedule I

DEFINITIONS

As used in this Agreement, the following terms have the following meanings:

	 	(a)	 	“Collateral” means all goods, accounts (including, without limitation,
health-care insurance receivables), equipment, inventory, contract rights or rights to
payment of money, leases, license agreements, franchise agreements, general intangibles,
commercial tort claims, documents, instruments (including, without limitation, any
promissory notes), chattel paper (whether tangible or electronic), cash, deposit accounts,
investment accounts, commodity accounts, all certificates of deposit, fixtures, letters of
credit rights (whether or not the letter of credit is evidenced by a writing), securities,
and all other investment property, supporting obligations, and financial assets, whether
now owned or hereafter acquired, wherever located; and all of each Grantor’s books relating
to the foregoing, and any and all claims, rights and interests in any of the above and all
substitutions for, additions, attachments, accessories, accessions and improvements to and
replacements, products, proceeds and insurance proceeds of any or all of the foregoing.

	 	(b)	 	“Governmental Approval” is any consent, authorization, approval, order,
license, franchise, permit, certificate, accreditation, registration, filing or notice, of,
issued by, from or to, or other act by or in respect of, any Governmental Authority.

	 	(c)	 	“Governmental Authority” is any nation or government, any state or other
political subdivision thereof, any agency, authority, instrumentality, regulatory body,
court, central bank or other entity exercising executive, legislative, judicial, taxing,
regulatory or administrative functions of or pertaining to government, any securities
exchange and any self-regulatory organization.

	 	(d)	 	“Indebtedness” is (a) indebtedness for borrowed money, (b) obligations
evidenced by notes, bonds, debentures or similar instruments, (c) obligations for the
deferred price of property or services (including, without limitation, reimbursement and
other obligations for surety bonds and letters of credit), (d) capital lease obligations,
(e) any obligation that is secured by a Lien and (f) contingent obligations with respect to
any of the foregoing.

	 	(e)	 	“Insolvency Proceeding” is any proceeding by or against any Person under the
United States Bankruptcy Code, or any other bankruptcy or insolvency law, including,
without limitation, assignments for the benefit of creditors, compositions, extensions
generally with its creditors, or proceedings seeking reorganization, arrangement, or other
relief.

	 	(f)	 	“Lien” means a claim, mortgage, deed of trust, levy, charge, pledge, security
interest or other encumbrance of any kind, whether voluntarily incurred or arising by
operation of Law or otherwise against any property.

	 	(g)	 	“Obligations” means all of the obligations and liabilities of each Grantor to
HSI, individually or collectively, whether direct or indirect (including any obligations
under any guaranties), joint or several, absolute or contingent, due or to become due, now
existing or hereafter arising under the Distribution Agreement, and any purchase orders
issued thereunder, including, without limitation, the Total Advances.

 

11

 

	 	(h)	 	“Permitted Indebtedness” means:

	 	i.	 	Biolase’s obligations to HSI under the Distribution Agreement;

	 
	 	ii.	 	Indebtedness existing on the date hereof as set forth in Schedule
V hereto;

	 
	 	iii.	 	Subordinated Debt;

	 
	 	iv.	 	unsecured Indebtedness to trade creditors incurred in the ordinary
course of business;

	 
	 	v.	 	Indebtedness secured by Permitted Liens;

	 
	 	vi.	 	Indebtedness of Biolase under the MidCap Loan Agreement in an amount
not to exceed an aggregate principal amount of $3,000,000 (the “MidCap
Debt”); and

	 
	 	vii.	 	extensions, refinancings, modifications, amendments and restatements of
any items of Permitted Indebtedness (a) through (f) above, provided that the
principal amount thereof is not increased or the terms thereof are not modified to
impose more burdensome terms upon any Grantor or its subsidiary, as the case may
be.

	 	(i)	 	“Permitted Liens” means:

	 	i.	 	Liens existing on the date first written above (including, without
limitation, Liens granted pursuant to the MidCap Loan and Security Agreement) or
arising under this Agreement;

	 
	 	ii.	 	Liens for taxes, fees, assessments or other government charges or
levies, either not delinquent or being contested in good faith and for which each
Grantor maintains adequate reserves on its books, provided that no notice of any
such Lien has been filed or recorded under the Internal Revenue UCC of 1986, as
amended, and the Treasury Regulations adopted thereunder;

	 
	 	iii.	 	purchase money Liens (i) on equipment acquired or held by each Grantor
incurred for financing the acquisition of the equipment securing no more than One
Hundred Thousand Dollars ($100,000) in the aggregate amount outstanding, or (ii)
existing on equipment when acquired, if the Lien is confined to the property and
improvements and the proceeds of the equipment; and

	 
	 	iv.	 	Liens incurred in the extension, renewal or refinancing of the
indebtedness secured by Liens described in (a) and (c) above, but any extension,
renewal or replacement Lien must be limited to the property encumbered by the
existing Lien and the principal amount of the Indebtedness may not increase.

 

12

 

	 	(j)	 	“Person” means any individual, sole proprietorship, partnership, limited
liability company, joint venture, company, trust, unincorporated organization, association,
corporation, institution, public benefit corporation, firm, joint stock company, estate,
entity or government agency.

	 
	 	(k)	 	“State” means the State of New York.

	 
	 	(l)	 	“Subordinated Debt” means indebtedness incurred by each Grantor subordinated to
all of its’ now or hereafter indebtedness to HSI (pursuant to a subordination,
intercreditor, or other similar agreement in form and substance satisfactory to HSI entered
into between each Grantor and the other creditor), on terms acceptable to HSI.

	 
	 	(m)	 	“UCC” means UCC, as the same may, from time to time, be enacted and in effect
in the State of New York; provided, that, to the extent that the UCC is used to define any
term herein and such term is defined differently in different Articles of the UCC, the
definition of such term contained in Article 9 shall govern; provided further, that in the
event that, by reason of mandatory provisions of law, any or all of the attachment,
perfection, or priority of, or remedies with respect to, HSI’s security interest on any
Collateral is governed by the UCC in effect in a jurisdiction other than the State of New
York, the term “UCC” shall mean the UCC as enacted and in effect in such other
jurisdiction solely for purposes of the provisions thereof relating to such attachment,
perfection, priority, or remedies and for purposes of definitions relating to such
provisions. All terms defined in the UCC and used herein (whether or not capitalized)
shall have the same definitions herein as specified therein.

 

13

 

Schedule II

REPRESENTATIONS AND WARRANTIES

Each Grantor hereby represents and warrants to HSI as follows:

	 	(a)	 	Each Grantor is (x) duly existing and in good standing, as a registered organization in
its jurisdictions of organization and (y) qualified and licensed to do business and is in
good standing in any jurisdiction in which the conduct of its business or its ownership of
property requires that it be qualified, except, in the case of clause (y) where the failure
to do so could not reasonably be expected to have a material adverse effect on each
Grantor’s business;

	 
	 	(b)	 	Each Grantor’s exact legal name is that indicated on the signature page hereof;

	 	(c)	 	Each Grantor is an organization of the type, and is organized in the jurisdiction set
forth in the first paragraph of this Agreement;

	 	(d)	 	Each Grantor’s organizational identification number is that indicated on the signature
page hereof;

	 	(e)	 	Each Grantor’s place of business as well as each Grantor’s mailing address is that
indicated on the signature page hereof;

	 	(f)	 	the execution, delivery and performance by each Grantor of this Agreement have been
duly authorized, and does not (i) conflict with any of its’ organizational documents, (ii)
contravene, conflict with, constitute a default under or violate any material law, (iii)
contravene, conflict or violate any applicable order, writ, judgment, injunction, decree,
determination or award of any Governmental Authority by which it or any of its subsidiaries
or any of their property or assets may be bound or affected, (iv) require any action by,
filing, registration, or qualification with, or Governmental Approval from, any
Governmental Authority (except such Governmental Approvals which have already been obtained
and are in full force and effect), or (v) constitute an event of default under any material
agreement (including, without limitation, the MidCap Loan Agreement) by which it or any of
its subsidiaries or their respective properties is bound;

	 	(g)	 	Each Grantor is the owner of or has other rights in or power to transfer the
Collateral, free from any right or claim or any person or any adverse lien, security
interest or other encumbrance, except for the security interest created by this Agreement;

	 	(h)	 	Each Grantor and each of its subsidiaries have obtained all consents, approvals and
authorizations of, made all declarations or filings with, and given all notices to, all
Governmental Authorities that are necessary to continue their respective businesses as
currently conducted;

	 	(i)	 	there are no actions or proceedings pending or, to the knowledge of each Grantor,
threatened in writing by or against it or any of its subsidiaries involving more than One
Hundred Thousand Dollars ($100,000.00), other than what has been disclosed in all
reports on Form 10-K, 10-Q and 8-K filed with the Securities and Exchange Commission;

 

14

 

	 	(j)	 	after giving effect to the transactions contemplated in the Distribution Agreement (i)
the fair salable value of each Grantor’s assets (including, without limitation, goodwill
minus disposition costs) exceeds the fair value of its liabilities, (ii) each Grantor is
not left with unreasonably small capital, and (iii) each Grantor is able to pay its debts
(including, without limitation, trade debts) as they mature;

	 	(k)	 	Each Grantor is not an “investment company” or a company “controlled” by an “investment
company” under the Investment Company Act of 1940, as amended;

	 	(l)	 	Each Grantor is not engaged as one of its important activities in extending credit for
margin stock (under Regulations X, T and U of the Federal Reserve Board of Governors);

	 	(m)	 	Each Grantor has not violated any Laws, ordinances or rules, the violation of which
could reasonably be expected to have a material adverse effect on its business; and

	 	(n)	 	Each Grantor has timely filed all required tax returns and reports, and Grantor and its
subsidiaries have timely paid all foreign, federal, state and local taxes, assessments,
deposits and contributions owed by it. Each Grantor may defer payment of any contested
taxes, provided that it (a) in good faith contests its obligation to pay the taxes by
appropriate proceedings promptly and diligently instituted and conducted, (b) notifies HSI
in writing of the commencement of, and any material development in, the proceedings, and
(c) posts bonds or takes any other steps required to prevent the governmental authority
levying such contested taxes from obtaining a Lien upon any of the Collateral that is other
than a Permitted Lien.

	 	(o)	 	The February Obligations amount to $2,461,908 and the March Obligations amount to
$3,540,842, in each case, as of the date first written above.

 

15

 

Schedule III

COVENANTS

Each Grantor covenants with HSI to:

	 	(a)	 	Government Compliance.

	 	i.	 	Maintain its and all its subsidiaries’ legal existence and good
standing in their respective jurisdictions of formation and maintain qualification
in each jurisdiction in which the failure to so qualify could reasonably be
expected to have a material adverse effect on its business or operations.

	 	ii.	 	Comply, and have each subsidiary comply, with all laws, ordinances and
regulations to which it is subject, the noncompliance with which could reasonably
be expected to have a material adverse effect on its business.

	 	iii.	 	Obtain and keep in full force and effect, all of the Governmental
Approvals necessary for the performance by it of its obligations under this
Agreement and the Distribution Agreement and the grant of a security interest to
HSI, in all of the Collateral.

	 	iv.	 	Promptly provide copies of any such obtained Governmental Approvals to
HSI.

	 	(b)	 	Financial Statements, Reports, Certificates.

	 	i.	 	Deliver to HSI: (i) as soon as available, but no later than one
hundred twenty (120) days after the last day of its fiscal year, audited
consolidated financial statements prepared under GAAP, consistently applied,
together with an unqualified (other than a “going concern” qualification) opinion
on the financial statements from its independent certified public accounting firm,
(ii) within five (5) days of filing, all reports on Form 10-K, 10-Q and 8-K filed
with the Securities and Exchange Commission or a link thereto on Biolase’s or
another website on the Internet and (iii) promptly upon receipt thereof, it shall
deliver to HSI any default notice or notice of enforcement action received pursuant
to any agreement evidencing Indebtedness in excess of $100,000.

	 	ii.	 	Give prompt written notice to HSI of any litigation or governmental
proceedings pending or threatened (in writing) against it which would reasonably be
expected to have a material adverse effect with respect to its business.

	 	iii.	 	Without limiting or contradicting any other more specific provision of
this Agreement, promptly (and in any event within three (3) Business Days) upon it
becoming aware of the existence of any Event of Default or event which, with the
giving of notice or passage of time, or both, would constitute an Event of Default,
it shall give written notice to HSI of such occurrence, which such notice shall
include a reasonably detailed description of such Event of Default or event which,
with the giving of notice or passage of time, or both, would constitute an Event of
Default.

 

16

 

	 	(c)	 	Insurance.

	 	i.	 	Maintain with financially sound and reputable insurers insurance with
respect to its properties and business against such casualties and contingencies as
shall be in accordance with general practices of businesses engaged in similar
activities in similar geographic areas. Such insurance shall be in such minimum
amounts that each Grantor will not be deemed a co-insurer under applicable
insurance laws, regulations and policies and otherwise shall be in such amounts,
contain such terms, be in such forms and be for such periods as may be reasonably
satisfactory to HSI. In addition, all such insurance shall be payable to HSI as
loss payee.

	 	ii.	 	All policies of insurance shall provide for at least 30 days prior
written cancellation notice to HSI. In the event of failure by each Grantor to
provide and maintain insurance as herein provided, HSI may, at its option, provide
such insurance and charge the amount thereof to it. Each Grantor shall furnish HSI
with certificates of insurance and policies evidencing compliance with the
foregoing insurance provision.

	 	(d)	 	Dispositions. Not convey, sell, lease, transfer, assign, or otherwise dispose
of (collectively, “Transfer”), or permit any of its subsidiaries to Transfer, all
or any part of its business or property, except for Transfers (a) of inventory in the
ordinary course of business; (b) of worn-out or obsolete equipment; or (c) in connection
with Permitted Liens and Permitted Investments.

	 
	 	(e)	 	Changes in Business, Management, Ownership, or Business Locations.
(a) Not engage in or permit any of its subsidiaries to engage in any business other than the
businesses currently engaged in by each Grantor and such Subsidiary, as applicable, or
reasonably related thereto; (b) not liquidate or dissolve; or (c) not permit or suffer any
Change in Control. “Change in Control” means any event, transaction, or occurrence
as a result of which (a) any “person” (as such term is defined in Sections 3(a)(9) and
13(d)(3) of the Exchange Act), other than a trustee or other fiduciary holding securities
under an employee benefit plan of such Grantor, is or becomes a beneficial owner (within the
meaning Rule 13d-3 promulgated under the Exchange Act), directly or indirectly, of
securities of such Grantor, representing twenty-five percent (25%) or more of the combined
voting power of such Grantor’s then outstanding securities; or (b) during any period of
twelve consecutive calendar months, individuals who at the beginning of such period
constituted the Board of Directors of such Grantor (together with any new directors whose
election by the Board of Directors of such Grantor was approved by a vote of not less than
two-thirds of the directors then still in office who either were directions at the beginning
of such period or whose election or nomination for election was previously so approved)
cease for any reason other than death or disability to constitute a majority of the
directors then in office.

 

17

 

	 	(f)	 	Indebtedness. Not create, incur, assume, or be liable for any Indebtedness, or
permit any Subsidiary to do so, other than Permitted Indebtedness.

	 	(g)	 	Encumbrance. Not create, incur, allow, or suffer any Lien on any of its
property, or assign or convey any right to receive income, including, without limitation,
the sale of any accounts, or permit any of its subsidiaries to do so, except for Permitted
Liens, or enter into any agreement, document, instrument or other arrangement (except with
or in favor of HSI) with any Person which directly or indirectly prohibits or has the
effect of prohibiting each Grantor or any subsidiary from assigning, mortgaging, pledging,
granting a security interest in or upon, or encumbering any of each Grantor’s or any
subsidiary’s Collateral, except as is otherwise permitted in clause (d) above and the
definition of “Permitted Liens”.

	 	(h)	 	Subordinated Debt. Not (a) make or permit any payment on any Subordinated
Debt, except under the terms of the subordination, intercreditor, or other similar
agreement to which such Subordinated Debt is subject, or (b) amend any provision in any
document relating to the Subordinated Debt which would increase the amount thereof or
adversely affect the subordination thereof to Obligations owed to HSI.

	 	(i)	 	Compliance. Not become an “investment company” or a company controlled by an
“investment company”, under the Investment Company Act of 1940, as amended and not
undertake as one of its important activities extending credit to purchase or carry margin
stock (as defined in Regulation U of the Board of Governors of the Federal Reserve System),
or use the proceeds of any Obligations for that purpose. 

	 	(j)	 	Use of Proceeds. Use the prepaid advances for general working capital
purposes, but in no event to repay any Indebtedness described in clauses (a), (b) or (f) of
the definition thereof.

 

18

 

Schedule IV

EVENTS OF DEFAULT

The following shall constitute Events of Default:

	 	(a)	 	Delivery/Payment Default. Biolase fails to deliver Products in accordance with
the Distribution Agreement (including, without limitation, under the $9.0M Purchase Order
or the Consumables Purchase Order) or pay cash in lieu thereof in amounts required under
the Distribution Agreement, after giving effect to the applicable cure period set forth in
Section 4.4(iv) of the Distribution Agreement;

	 	(b)	 	Termination of Distribution Agreement. The Distribution Agreement shall
terminate or cease to be in effect for any reason prior to the full and indefeasible
satisfaction of all obligations under the $9.0M Purchase Order and all other prepaid
advances thereunder (or purchase orders related thereto).

	 	(c)	 	Covenant Default. Each Grantor or any of its Subsidiaries fails or neglects to
perform, keep, or observe any other term, provision, condition, covenant or agreement
contained in this Agreement or the Distribution Agreement, as applicable, and as to any
default (other than those specified in clause (a) above) under such other term, provision,
condition, covenant or agreement that can be cured, has failed to cure the default within
thirty (30) days after the occurrence thereof (provided that this cure period shall
not be applicable to any provision of the Distribution Agreement that already has a cure
period);

	 	(d)	 	Insolvency. (a) AGrantor is unable to pay its debts (including, without
limitation, trade debts) as they become due or otherwise becomes insolvent; (b) A Grantor
begins an Insolvency Proceeding; or (c) an Insolvency Proceeding is begun against a Grantor
and not dismissed or stayed within sixty (60) days;

	 	(e)	 	Other Agreements. There is a default in the MidCap Loan Agreement or any
agreement to which a Grantor is a party with a third party or parties and, as a result
thereof, the maturity of any Indebtedness in an amount in excess of One Hundred Thousand
Dollars ($100,000) under any such agreement is accelerated, or any enforcement action with
respect to such Indebtedness, or any assets securing such Indebtedness, is taken by any
such third party;

 

19

 

	 	(f)	 	Judgments. One or more unappealable judgments, orders, or decrees for the
payment of money in an amount, individually or in the aggregate, of at least Two Hundred
and Fifty Thousand Dollars ($250,000) (not covered by independent third-party insurance as
to which liability has been accepted by such insurance carrier) shall be rendered against a
Grantor and shall remain unsatisfied, unvacated, or unstayed for a period of thirty (30)
days after the entry thereof;

	 	(g)	 	Misrepresentations. A Grantor makes any representation or warranty in this
Agreement, and such representation or warranty is incorrect in any material respect when
made; and

	 	(h)	 	Lien Priority. Except as permitted by HSI, any Lien created hereunder shall at
any time fail to constitute a valid Senior Priority perfected Lien on all of the Collateral
purported to be secured hereunder.

 

20

 

Schedule V

EXISTING INDEBTEDNESS

 

21Exhibit 10.7

Exhibit 10.7

WAIVER AND AMENDMENT NO. 1 TO LOAN AND

SECURITY AGREEEMNT

This Waiver and Amendment No. 1 to Loan and Security Agreement (this “Amendment”) is entered
into as of September 23, 2010 by and among MIDCAP FUNDING III, LLC, a Delaware limited liability
company (as successor to MidCap Financial, LLC), with an office located at 7735 Old Georgetown
Road, Suite 400, Bethesda, Maryland 20814 (“MidCap”), as collateral agent (“Agent”), and as a
“Lender”, SILICON VALLEY BANK, a California corporation and with a loan production office located
at 5820 Canoga Avenue, Suite 210, Woodland Hills, California 91367 (“SVB”), as a “Lender” (MidCap
and SVB in their capacities as “Lenders” are referred to herein each as a “Lender” and
collectively as the “Lenders”), and BIOLASE TECHNOLOGY, INC., a Delaware corporation (“Borrower”).

1. DESCRIPTION OF EXISTING INDEBTEDNESS AND OBLIGATIONS. Among other indebtedness and
obligations which may be owing by Borrower to Lender, Borrower is indebted to Lender pursuant to a
certain loan arrangement, evidenced by, among other documents, instruments and agreements, the
following (collectively, together with all other documents, instruments and agreements evidencing
or securing the Obligations, the “Loan Documents”): (i) the Loan and Security Agreement dated as of
May 27, 2010 by and among Agent, the Lenders and Borrower (the “Loan Agreement”); (ii) the Secured
Promissory Note in the original principal amount of $2,100,000 dated May 27, 2010 made by Borrower
payable to MidCap; (iii) the Secured Promissory Note in the original principal amount of $900,000
dated May 27, 2010 made by Borrower payable to SVB; (iv) the Intellectual Property Security
Agreement dated as of May 27, 2010 by and among Borrower, Agent and the Lenders (the “Intellectual
Property Security Agreement”); (v) the Unconditional Guaranty dated as of May 27, 2010 made by BL
ACQUISITION CORP., a Delaware corporation (“BL Acquisition”) and BL ACQUISITION II, INC.,
a Delaware corporation (“BL Acquisition II” and individually and collectively, jointly and
severally with BL Acquisition, the “Guarantor”) in favor of Agent and the Lenders; and (vi) the
Security Agreement dated as of May 27, 2010 made by the Guarantor in favor of Agent and the Lenders
(the “Security Agreement”). Capitalized terms used but not otherwise defined herein shall have the
same meaning as in the Loan Agreement.

Reference is also made to the Forbearance Agreement, dated as of August 16, 2010, by and among
Agent, the Lenders and Borrower (the “Forbearance Agreement”). Pursuant to the terms of the
Forbearance Agreement, the Lenders have agreed to forbear during the Forbearance Period (as defined
in the Forbearance Agreement), and have so forbeared to and including the date hereof, from
exercising its rights and remedies in respect of the Events of Default arising due to Borrower’s
failure to comply with the financial covenant contained in Section 6.11(a) of the Loan Agreement on
the Testing Date occurring on July 1, 2010 (the “July Event of Default”). In addition, Borrower has
informed Agent and the Lenders that Borrower does not expect to comply with the financial covenant
contained in Section 6.11(a) of the Loan Agreement on the Testing Date occurring on October 1, 2010
(the “October Event of Default” and collectively with the July Event of Default, the “Existing
Defaults”) .

2. DESCRIPTION OF COLLATERAL. Repayment of the Obligations is secured by the Collateral as
described in the Loan Agreement, the Intellectual Property Security Agreement and the Security
Agreement.

3. DESCRIPTION OF CHANGE IN TERMS.

A. Modifications to Loan Agreement.

1. The Loan Agreement shall be amended by deleting the
following, appearing as Section 2.2(b) thereof:

“(b) Interest Payments and Repayment. Commencing on the first
(1st) Payment Date following the Funding Date of Term A
Loan, and continuing on the Payment Date of each successive month
thereafter through and including the Maturity Date, Borrower shall
make monthly payments of interest to Agent, for payment to each
Lender in accordance with its respective Pro Rata Share, in arrears,
and calculated as set forth
in Section 2.3. Commencing on the Amortization Date, and
continuing on the Payment Date of each successive month thereafter
through and including the Maturity Date, Borrower shall make
consecutive monthly payments of principal to Agent, for payment to
each Lender in accordance with its respective Pro Rata Share, as
calculated by Agent based upon: (1) the amount of such Lender’s Term
Loans, (2) the effective rate of interest, as determined in
Section 2.3, and (3) a straight-line amortization schedule ending on
the Maturity Date. All unpaid principal and accrued interest with
respect to the Term Loans is due and payable in full on the Maturity
Date. The Term Loans may be prepaid only in accordance with Sections
2.2(c) and 2.2(d).”

 

 

and inserting in lieu thereof the following:

“(b) Interest Payments and Repayment. Commencing on the first
(1st) Payment Date following the Funding Date of Term A
Loan, and continuing on the Payment Date of each successive month
thereafter through and including the Maturity Date, Borrower shall
make monthly payments of interest to Agent, for payment to each
Lender in accordance with its respective Pro Rata Share, in arrears,
and calculated as set forth in Section 2.3. Commencing on the
Amortization Date, and continuing on the Payment Date of each
successive month thereafter through and including the Maturity Date,
Borrower shall make consecutive monthly payments of principal to
Agent, for payment to each Lender in accordance with its respective
Pro Rata Share, as calculated by Agent based upon: (1) the amount of
such Lender’s Term Loans, (2) the effective rate of interest, as
determined in Section 2.3, and (3) a straight-line amortization
schedule ending on the Maturity Date (provided that for the Payment
Dates occurring on April 1, 2011 through and including December 1,
2011, the aggregate principal amortization of Term A Loan shall be
$125,000 per month and allocated to each Lender in accordance with
its respective Pro Rata Share). All unpaid principal and accrued
interest with respect to the Term Loans is due and payable in full on
the Maturity Date. The Term Loans may be prepaid only in accordance
with Sections 2.2(c) and 2.2(d).”

2. The Loan Agreement shall be amended by adding the following
sentence at the end of Section 2.2(d) thereof:

“Notwithstanding the foregoing, Borrower shall be permitted to
optionally prepay all or any portion of the Term A Loans on or before
March 31, 2011, provided Borrower (i) provides written notice to
Agent of its election to prepay the Term A Loans at least five (5)
days prior to such prepayment, and (ii) pays to Agent, for payment to
each Lender in accordance with its respective Pro Rata Share, on the
date of such prepayment, an amount equal to the sum of (A) the
principal amount of the Term A Loans being prepaid, plus accrued
interest thereon, (B) the
Final Payment in respect of the principal amount of the Term A
Loans being prepaid, and (C) all other sums that shall have become
due and payable, including Lenders’ Expenses (but not including any
Prepayment Fee in respect of the principal amount of the Term A Loans
being prepaid). The provisions of the foregoing sentence shall not
apply to any prepayment of the Term A Loans upon the acceleration of
the Term A Loans.”

 

2

 

3. The Loan Agreement shall be amended by adding the following
new clauses (f) and (g) to Section 6.2 thereof:

“(f) Deliver to Agent and the Lenders on the first Business Day
of each week, (i) a prospective cash flow forecast for the thirteen
(13) week period commencing on such day and (ii) a report detailing
the unit sales performance of Borrower and its Subsidiaries in the
week preceding such day.

(g) Deliver to Agent and the Lenders on or before December 31 of
each year, annual sales projections on a month-by-month basis for the
succeeding calendar year (the “Annual Projections”).”

4. The Loan Agreement shall be amended by adding the following
new section, appearing as Section 6.15 thereof:

“6.15 Subsequent Financing Event. Borrower shall close
the Required Equity Financing on or before March 31, 2011. Borrower
shall remit to Agent all proceeds of each Subsequent Equity Event for
application to the repayment of the Term A Loans in accordance with
Section 2.2(d) immediately upon receipt of such proceeds by Borrower.
In addition, in the event the (i) the Required Equity Financing does
not close on or before March 31, 2011 or (ii) the Required Equity
Financing closes on or before March 31, 2011 and results in the
receipt by Borrower of aggregate net cash proceeds of less than
$5,000,000, on or before April 5, 2011, Borrower shall issue, execute
and deliver to each Lender additional stock purchase warrants (the
“Additional Warrants”), in substantially the same form as the stock
purchase warrants issued by Borrower to the Lenders of the Effective
Date (the “Existing Warrants”). The Additional Warrants shall have
terms and conditions substantially identical to the Existing Warrants
and shall have a term of five (5) years from date of issuance,
representing in the aggregate (such aggregate to be allocated among
the Lenders proportionally in the same proportions as the Existing
Warrants) the right to purchase such number of shares of Borrower’s
common stock (calculated as of the business day immediately prior to
the date of issuance) as shall equal to the Applicable Percentage (as
defined below) of Borrower’s then-total issued and outstanding common
stock  determined on a fully-diluted, as-exercised, as-converted
basis, at an exercise price per share equal to the lowest
closing price per share of Borrower’s common stock reported on
the NASDAQ Capital Market reported for the twenty (20) trading days
immediately preceding the date of issuance. “Applicable Percentage”
shall mean (i) two and one-half percent (2.50%) if the Required
Equity Financing does not close on or before March 31, 2011 or (ii)
one and one-half percent (1.50%) if the Required Equity Financing
closes on or before March 31, 2011 and results in the receipt by
Borrower of aggregate net cash proceeds equal to or greater than
$3,000,000 but less than $5,000,000.”

 

3

 

5. The Loan Agreement shall be amended by deleting the “.” at
the end of Section 8.13 and replacing it with “;” and adding the
following new section, appearing as Section 8.14 thereof:

“8.14 Monthly Unit Sales. Commencing with the month
ending October 31, 2010 and continuing on the last day of each month
thereafter, Borrower shall fail to achieve monthly unit sales for any
two consecutive months (tested as of the last day of each month) of
at least 80% of the unit sales projected for such months (i) with
respect to October, November and December, 2010, as set forth in
Borrower’s business plan attached hereto as Exhibit E and (ii)
thereafter, as set forth in Borrower’s Annual Projections as approved
by Agent and the Lenders.”

6. The Loan Agreement shall be amended by deleting the
following, appearing as Section 8.2(a) thereof:

“(a) Borrower fails or neglects to perform any obligation in
Sections 6.1(c), 6.2, 6.4, 6.5, 6.6, 6.7, 6.10, or 6.11 or violates
any covenant in Section 7; or”

and inserting in lieu thereof the following:

“(a) Borrower fails or neglects to perform any obligation in
Sections 6.1(c), 6.2, 6.4, 6.5, 6.6, 6.7, 6.10, 6.11, 6.15 or 6.16 or
violates any covenant in Section 7; or”

7. The Loan Agreement shall be amended by deleting the
following, appearing as Section 8.12 thereof:

“Lien Priority. Except as permitted by Agent, any Lien
created hereunder or by any other Loan Document shall at any time
fail to constitute a valid and perfected Lien on all of the
Collateral purported to be secured thereby, subject to no prior or
equal Lien; or”

 

4

 

and inserting in lieu thereof the following:

“Lien Priority. Except as permitted by Agent, any Lien
created hereunder or by any other Loan Document shall at any time
fail to constitute a valid and perfected Lien on all of the
Collateral purported to be secured thereby, subject to no prior or
equal Lien (other than Liens in favor of Henry Schein, Inc. provided
that such Liens (i) secure only the obligations of Borrower pursuant
to the Schein Distribution Agreement as in effect on the Loan
Modification Agreement and (ii) are subject to an Intercreditor
Agreement, by and among Agent, the Lenders and Henry Schein, Inc. in
form and substance acceptable to Agent and the Lenders); or”

8. The Loan Agreement shall be amended by deleting the
following definitions appearing in Section 13.1 thereof:

““Amortization Date” is December 1, 2010.

“Payment Date” is the first calendar day of each calendar month.

“Permitted Liens” are:

(a) Liens existing on the Effective Date and shown on the
Perfection Certificate or arising under this Agreement and the other
Loan Documents;

(b) Liens for taxes, fees, assessments or other government
charges or levies, either not delinquent or being contested in good
faith and for which Borrower maintains adequate reserves on its
Books, provided that no notice of any such Lien has been filed or
recorded under the Internal Revenue Code of 1986, as amended, and
the Treasury Regulations adopted thereunder;

(c) purchase money Liens (i) on Equipment acquired or held by
Borrower incurred for financing the acquisition of the Equipment
securing no more than One Hundred Thousand Dollars ($100,000) in the
aggregate amount outstanding, or (ii) existing on Equipment when
acquired, if the Lien is confined to the property and
improvements and the proceeds of the Equipment; and

(d) Liens incurred in the extension, renewal or refinancing of
the indebtedness secured by Liens described in (a) and (c) above,
but any extension, renewal or replacement Lien must be
limited to the property encumbered by the existing Lien and the
principal amount of the Indebtedness may not increase.”

and inserting in lieu thereof the following:

““Amortization Date” is October 1, 2010.

 

5

 

“Payment Date” is the first calendar day of each calendar month;
provided that the Payment Date in each month during the period
commencing on October 1, 2010 through and including March 1, 2011
shall be the 10th calendar day of the month.

“Permitted Liens” are:

(a) Liens arising under this Agreement and the other Loan
Documents;

(b) Liens for taxes, fees, assessments or other government
charges or levies, either not delinquent or being contested in good
faith and for which Borrower maintains adequate reserves on its
Books, provided that no notice of any such Lien has been filed or
recorded under the Internal Revenue Code of 1986, as amended, and
the Treasury Regulations adopted thereunder;

(c) purchase money Liens (i) on Equipment acquired or held by
Borrower incurred for financing the acquisition of the Equipment
securing no more than One Hundred Thousand Dollars ($100,000) in the
aggregate amount outstanding, or (ii) existing on Equipment when
acquired, if the Lien is confined to the property and
improvements and the proceeds of the Equipment;

(d) Liens incurred in the extension, renewal or refinancing of
the indebtedness secured by Liens described in (a) and (c) above,
but any extension, renewal or replacement Lien must be
limited to the property encumbered by the existing Lien and the
principal amount of the Indebtedness may not increase; and

(e) Liens in favor of Henry Schein, Inc. granted pursuant to
that certain Amended and Restated Security Agreement dated as of
September
 _____, 2010 by and between Borrower and Henry Schein, Inc.
provided that such Liens (i) secure only the obligations of Borrower
pursuant to the Schein Distribution Agreement as in effect on the
Loan Modification Agreement and (ii) are subject to an Intercreditor
Agreement, by and among Agent, the Lenders and Henry Schein, Inc. in
form and substance acceptable to Agent and the Lenders.”

9. The Loan Agreement shall be further amended by adding the
following, definitions in Section 13.1 thereof in alphabetical order:

“Loan Modification Date” means September
 _____, 2010.”

“Required Equity Financing” means the receipt by Borrower, on or
after the Loan Modification Date, of aggregate net cash proceeds of
not less than $3,000,000 from one or more Subsequent Equity Events
and application of 100% such net proceeds to the prepayment of
the Term A Loans in accordance with Section 2.2(d).”

 

6

 

“Schein Distribution Agreement” means the Distribution and
Supply Agreement dated as of September
 _____, 2010 by and between
Borrower and Henry Schein, Inc.

“Schein Security Agreement” means the Amended and Restated
Security Agreement dated as of September
 _____, 2010 by and between
Borrower and Henry Schein, Inc.

“Subsequent Equity Event” means the receipt by Borrower, on or
after the Loan Modification Date, of net cash proceeds from an equity
or subordinated convertible debt financing and/or licensing or joint
venture or corporate collaboration transaction.”

4. WAIVER. Borrower acknowledges the Existing Defaults. In consideration of and in
reliance upon the representations, warranties and covenants of Borrower herein and in the Loan
Documents, the Lenders hereby waive the Existing Defaults under the Loan Agreement. The Lenders’
agreement to waive the Existing Defaults as set forth in this Amendment in no way shall obligate
the Lenders to waive or forbear in the future or otherwise make any future modifications to the
Loan Documents or the Obligations.

5. REPRESENTATION AND WARRANTIES. To induce Agent and the Lenders to enter into this
Amendment, Borrower hereby represents and warrants to Agent and the Lenders as follows: immediately
after giving effect to the waiver in Section 4 of this Amendment (a) the representations and
warranties of Borrower contained in the Loan Documents are true, accurate and complete in all
material respects as of the date hereof (except to the extent such representations and warranties
relate to an earlier date, in which case they are true and correct as of such date), and (b) no
Event of Default has occurred and is continuing and (b) Borrower has the power and authority to
execute and deliver this Amendment. Borrower understands and agrees that in entering into this
Amendment, Agent and the Lenders is relying upon Borrower’s representations, warranties, and
agreements, as set forth in the Loan Documents and herein.

6. CONSISTENT CHANGES. The Loan Documents are hereby amended wherever necessary to reflect
the changes described above.

7. RATIFICATION OF LOAN DOCUMENTS; ACKNOWLEDGEMENT OF OBLIGATIONS. Borrower hereby (a)
ratifies, confirms, and reaffirms each of the terms and conditions of the Loan Documents, (b)
acknowledges and agrees that except as previously amended in writing and as specifically modified
by this Amendment, all terms and conditions of the Loan Documents shall remain in full force and
effect, and (c) ratifies, confirms and reaffirms all terms and conditions of all security or other
collateral granted to Agent and the Lenders, and confirms that the indebtedness secured thereby
includes, without limitation, the Obligations. Nothing in this Amendment shall constitute a
satisfaction of the Obligations. It is the intention of Agent, the Lenders and Borrower to retain
as liable parties all makers of Loan Documents, unless the party is expressly released by Agent and
the Lenders in writing. No maker will be released by virtue of this Amendment. Borrower
acknowledges and agrees that the Term B Loan Draw Period never commenced and that the Lenders have
no obligation to make any Term B Loan available to Borrower.

8. NO DEFENSES OF BORROWER. Borrower hereby acknowledges and agrees that Borrower has no
offsets, defenses, claims, or counterclaims against Agent or any Lender with respect to the Loan
Documents, the Obligations, or otherwise, and that if Borrower now has, or ever did have, any
offsets, defenses, claims, or
counterclaims against Agent or any Lender, whether known or unknown, at law or in equity, all of
them are hereby expressly WAIVED and Borrower hereby RELEASES Agent and each Lender from any
liability thereunder.

 

7

 

9. WAIVER OF JURY TRIAL. Borrower hereby makes the following waiver knowingly, voluntarily,
and intentionally, and understand that Agent and the Lenders, in entering into this Amendment, are
expressly relying on such waiver: BORROWER HEREBY IRREVOCABLY WAIVES ANY PRESENT OR FUTURE RIGHT TO
A JURY IN ANY TRIAL OF ANY CASE OR CONTROVERSY IN WHICH BORROWER, ANY GUARANTOR, AGENT, OR ANY
LENDER IS OR BECOMES A PARTY (WHETHER SUCH CASE OR CONTROVERSY IS INITIATED BY OR AGAINST LENDER OR
IN WHICH LENDER IS JOINED AS A PARTY LITIGANT), WHICH CASE OR CONTROVERSY ARISES OUT OF, OR IS IN
RESPECT OF, ANY RELATIONSHIP AMONG BORROWER, ANY GUARANTOR, AGENT AND ANY LENDER. THIS PROVISION
IS A MATERIAL INDUCEMENT FOR AGENT AND THE LENDERS TO ENTER INTO THIS AMENDMENT.

10. FEES AND EXPENSES. In consideration of the execution and delivery by the Lenders of
this Amendment, Borrower shall pay the Lenders an amendment fee of $60,000 to be paid to the
Lenders in accordance with their respective Pro Rata Shares, which amendment fee is due and payable
on the earliest to occur of (i) prepayment in full of the Term A Loan under Section 2.2(d) of the
Loan Agreement, (ii) the acceleration of Term A Loan or (iii) the Maturity Date. In addition,
Borrower shall reimburse Agent and the Lenders on demand for any and all unreimbursed costs,
expenses, and costs of collection (including reasonable attorneys’ fees and expenses) heretofore
and hereafter incurred by Agent or any Lender in connection with the protection, preservation, and
enforcement by Agent or any Lender of Agent’s or any Lender’s rights and remedies under the Loan
Documents, including, without limitation, the negotiation and preparation of this Amendment.

11. COUNTERSIGNATURE. This Loan Modification Agreement shall become effective only upon
(i) execution and delivery by Borrower and Henry Schein, Inc. of the Schein Distribution Agreement
and the Schein Security Agreement on or before the Loan Modification Date, (ii) receipt by Agent
and the Lenders of a fully executed Intercreditor Agreement with Henry Schein, Inc. in form and
substance acceptable to Agent and the Lenders, (iii) receipt by Agent and the Lenders of evidence
satisfactory to Agent and the Lenders that Borrower has received net cash proceeds of not less than
$3,000,000 from Henry Schein, Inc. in connection with the execution and delivery of the Schein
Distribution Agreement, (iv) receipt by the Lenders of amendments to their respective Warrants in
form and substance acceptable to the Lenders, and (v) execution of this Amendment by Agent, the
Lenders and Borrower. It is the intention of the parties hereto that this Amendment may be
executed in any number of counterparts (including by facsimile or e-mail transmission of an adobe
file format document (also known as a PDF file)), and by the different parties hereto on the same
or separate counterparts, each of which shall be deemed to be an original instrument but all of
which together shall constitute one and the same agreement.

[The remainder of this page is intentionally left blank]

 

8

 

IN WITNESS WHEREOF, the parties hereto have caused this
Amendment to be executed as of the Loan Modification Date.

	 	 	 	 	 
	 	BORROWER:

BIOLASE TECHNOLOGY, INC.

 	 
	 	By:  	/s/ Federico Pignatelli
 	 
	 	 	Name:  	Federico Pignatelli 	 
	 	 	Title:  	Chairman and interim Chief Executive Officer 	 

	 	 	 	 	 
	 	AGENT:

MIDCAP FUNDING III, LLC, as Agent

 	 
	 	By:  	/s/ Luis Viera
 	 
	 	 	Name:  	Luis Viera 	 
	 	 	Title:  	Managing Director 	 

	 	 	 	 	 
	 	LENDERS:

MIDCAP FUNDING III, LLC, as a Lender

 	 
	 	By:  	/s/ Luis Viera
 	 
	 	 	Name:  	Luis Viera 	 
	 	 	Title:  	Managing Director 	 

	 	 	 	 	 
	 	SILICON VALLEY BANK, as a Lender

 	 
	 	By:  	/s/ Marla Johnson
 	 
	 	 	Name:  	Marla Johnson 	 
	 	 	Title:  	Senior Advisor 	 

 

9

 

ASSENT BY GUARANTOR:

For good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the undersigned Guarantor: (i)
hereby acknowledges and assents to the terms and conditions of the
foregoing Amendment; (ii) as and to the extent specified in the
foregoing Amendment, hereby joins with the Borrower in making the
representations, warranties, covenants, and agreements specified
therein as being applicable to the Guarantor by its assent hereunder;
(iii) hereby represents and warrants to the Lenders that the
execution and delivery of its assent hereunder and of the
instruments, documents, and agreements required by the Guarantor
under the Amendment and contemplated thereby have been determined by
the Guarantor: (x) to be in the best corporate interest of the
Guarantor, (y) to constitute the reasonably equivalent value with
respect to the benefit derived by the Guarantor therefrom, and (z) to
be the free and voluntary act of the Guarantor for such valid
consideration; and (iv) hereby submits to the jurisdiction of all
federal and state courts situated in the State of Maryland with
respect to all matters relating in any way to this Amendment and/or
the other Loan Documents.

	 	 	 	 	 
	 	GUARANTORS:

BL ACQUISITION CORP.

 	 
	 	By:  	/s/ Federico Pignatelli
 	 
	 	 	Name:  	Federico Pignatelli 	 
	 	 	Title:  	Chief Executive Officer 	 

	 	 	 	 	 
	 	BL ACQUISITION II, INC.

 	 
	 	By:  	/s/ Federico Pignatelli
 	 
	 	 	Name:  	Federico Pignatelli 	 
	 	 	Title:  	Chief Executive Officer 	 

 

10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00180-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00180-of-00352.parquet"}]]